BridgeMD
New treatment option for Infertility, Female
Official title A Couple-based Gender-transformative Intervention on IPV Against Infertile Women
ClinicalTrials.gov ID: NCT06124950
What this study is testing
- What it's testing
- This is a multicenter, open-label, randomized controlled trial conducted at two reproductive medicine centers in Beijing, China. Couples undergoing their first or second in-vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) cycle, diagnosed with female-factor infertility, and who have signed informed consent will be enrolled.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Couples who are undergoing their first or second IVF/ICSI cycle;
- Couples diagnosed with female-factor infertility;
- Couples who have signed consent.
You likely can't join if
- Couples who receive donated oocytes, sperm, or embryos;
- Couples diagnosed with severe male-factor infertility or unexplained infertility.
- Couples who are undergoing Preimplantation Genetic Testing (PGT);
- Couples who have not undergone embryo transfer within six months after oocyte retrieval;
- Couples who have severe mental disorders;
- Couples who withdrew from the study.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.